CARE revises ratings of Godavari Drugs’ bank facilities

12 Feb 2016 Evaluate

Credit rating agency, Credit Analysis & Research (CARE) has revised rating of Godavari Drugs’ long term bank facilities worth Rs 6 crore to ‘BB+’ from ‘BB’. The rating agency has also revised rating of company’s short term bank facilities worth Rs 15 crore to ‘A4+’ from ‘A4’. The revision in the ratings assigned to the bank facilities of Godavari Drugs (GDL) is on account of significant increase in the total operating income of the company during FY15 (refers to the period April 01 to March 31) backed by increase in focus on direct sales, diversified clientele and improved operating cycle.

The ratings are, however, constrained by decrease in profitability margins during FY15, product concentration risk and presence in highly fragmented industry with many unorganized players.

Godavari Drugs Share Price

114.50 1.00 (0.88%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.